Interior Health defends downtown safe consumption site amid Kelowna’s shutdown request - Nelson Star

University of Saskatchewan (USask) researchers used well-established methods to calculate the social return on investment (SROI) of Saskatoon's recently closed safe consumption site and have found that the location provided more than a 300% return on investment for the community. While a standard return on investment (ROI) strictly measures money invested against dollars gained or lost, an SROI looks at economics alongside the social and environmental outcomes, expressing the broader impact in financial terms.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.